Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EORTC 24954 Larynx Preservation Study
NCT00002839Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 1996
- Primary completion
- May 2004
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of cisplatin, fluorouracil in laryngeal cancer, hypopharyngeal cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 1996; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
laryngeal cancerhypopharyngeal cancer
Beyond the preview
Go deeper on NCT00002839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002839.